Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft.
Transcatheter aortic valve implantation (TAVI) in severe aortic stenosis has proven to be a feasible and effective treatment modality for inoperable patients. Until now, neither aortic regurgitation nor degenerated bioprostheses has been an indication for TAVI. However, this article reports a successful valve-in-valve implantation of a CoreValve aortic valve prosthesis through the right subclavian artery in a case of severe aortic regurgitation within a degenerated aortic homograft. The case exemplifies the possibilities of expanding the indications for TAVI, as well as other vascular access options than the femoral arteries.
Olsen
Lene Kjaer
LK
Department of Cardiology B 2014, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Engstrøm
Thomas
T
Søndergaard
Lars
L
D000369:Aged, 80 and over; D001021:Aortic Valve; D001022:Aortic Valve Insufficiency / Q000209:etiology / Q000628:therapy*; D002114:Calcinosis / Q000150:complications; D006328:Cardiac Catheterization / Q000295:instrumentation* / Q000379:methods*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D019737:Transplants / Q000009:adverse effects*; D016896:Treatment Outcome